GlassScriptPhysician profile
Gail S Weiser
NPI 1689712614
$1,488.94
in general payments reported to CMS, 2019-2025
12 companies · $99.84 in 2025
The $99.84 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $289 · 2022: $199 · 2023: $574 · 2024: $328 · 2025: $99.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $245.96 | 2021-2023 | Fasenra |
| Daiichi Sankyo INC. | $184.47 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $173.69 | 2021 | |
| Amgen INC. | $128.00 | 2024 | Evenity, Prolia |
| Novo Nordisk INC | $113.63 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $100.63 | 2023 | Austedo Xr |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $99.99 | 2024 | |
| Pfizer INC. | $99.84 | 2025 | |
| Alexion Pharmaceuticals, INC. | $99.52 | 2024 | |
| Inari Medical, INC. | $97.80 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Eisai INC. | $84.99 | 2022 | |
| Abbvie INC. | $60.42 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Weiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.